Such difference is possibly due to an insignificant inhibition of FASN activity in H3255 cells by 30 μM of orlistat in 24 h (Fig. 1) because these cells express threefold more FASN mRNA at baseline as compared to other NSCLC cell lines studied. This evidence concerns the gene FASN and non-small cell lung carcinoma.